Real-time enrollment status for this pulmonary arterial hypertension (pah) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:01 AM UTC
| NCT Number | NCT07318597 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Arterial Hypertension (PAH) |
| Phase | Clinical Trial |
| Target Enrollment | 99 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT07318597 is currently recruiting participants. This clinical trial study for pulmonary arterial hypertension (pah) is actively seeking new participants at 1 location across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07318597 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07318597 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.